Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion TransactionGlobeNewsWire • 11/06/24
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024GlobeNewsWire • 09/09/24
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024GlobeNewsWire • 09/03/24
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024GlobeNewsWire • 07/02/24
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024GlobeNewsWire • 07/01/24
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceGlobeNewsWire • 05/23/24
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024GlobeNewsWire • 04/24/24
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QGlobeNewsWire • 03/20/24
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024GlobeNewsWire • 03/06/24
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023GlobeNewsWire • 12/07/23
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023GlobeNewsWire • 11/30/23
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) ProgramsGlobeNewsWire • 11/08/23
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing FacilityGlobeNewsWire • 10/17/23
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO ConferenceGlobeNewsWire • 09/26/23
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023GlobeNewsWire • 09/07/23
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023GlobeNewsWire • 08/31/23
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023GlobeNewsWire • 06/21/23
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023GlobeNewsWire • 06/14/23
Avid Bioservices to Participate in RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/10/23
Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future CustomersGlobeNewsWire • 04/04/23
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent DevelopmentsGlobeNewsWire • 03/13/23